ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Greenbrook TMS (GBNH) Announces Increase to Bought Deal Financing to US$11.5 Million

TORONTO, September 22, 2021--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation...

Bright Minds Biosciences (BIMBF) Provides Scientific Update

Lead program, BMB-101, advances to IND-enabling toxicology studies with the aim of commencing human trials in 1H 2022

Small Pharma (DMTTF) Successfully Completes Phase I Clinical Trial Of DMT In Combination With Supportive Psychotherapy

Small Pharma's DMT-assisted therapy (SPL026) demonstrated to be well-tolerated and safe in psychedelic naïve volunteers Dataset generated from Phase...

Huge News on Opioid Addiction From atai (ATAI).

Every successful drug was once in Phase I. "In previously published non-controlled studies, ibogaine has demonstrated rapid and...

AdvisorShares Psychedelics ETF (PSIL)

The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies...

Ketamine One (KONEF) Signs LOI with Veteran Services USA to Open Therapy Center

Ketamine-Assisted Treatment Facility to Be Part of a Medical Complex in Blue Island, Illinois

atai Life Sciences (ATAI) Increases Investment in IntelGenx’s (IGXT).

atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility...

Novamind (NVMDF) Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF (PSIL)

(CSE: NM) TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental...

Horizons Psychedelic Index ETF.

CLICK TO VIEW WEBSITE PRODUCT SHEET

On-Demand Now: Life Sciences Psychedelic Company Presentations.

The presentations from their recent live event are now available for replay. The event featured CEOs and top executives from international companies engaged...

AdvisorShares Launches Psychedelics ETF (Ticker: PSIL)

AdvisorShares Psychedelics ETF delivers focused exposure to invest in a new medical frontier BETHESDA, Md., Sept. 16, 2021 /PRNewswire/ -- AdvisorShares, a...

Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental...

NeonMind (NMBDF) Announces Divestiture of Consumer Related and Other Non-Core Assets

CSE: (NEON) LIVE QUOTE Reflects Strategic Focus on Psychedelic Treatments...

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

500mg Iboga Total Alkaloid (TA) Extract. Someone posted this photo on LinkedIn, which we took as a tease....

$400 Million Man Tries Psychedelic Toads.

"This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer."

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS